Recent years have seen an unprecedented rise in the use of 3D culture systems, both in fundamental research 12
INTRODUCTION 25
Overview of 3D culture 26
The first attempts at culturing cells in 3D were made in the early 1980s, in particular with the pioneering 27 work of Mina Bissell and her lab (Bissel 1988). 3D cell culture techniques made incremental progress over 28 the years and slowly gained popularity in the scientific community, with an explosion of interest in the mid-29
2010s. In recent years, the interest in utilizing 3D cell cultures and organoids as an intermediate platform 30
for drug discovery and toxicity studies has skyrocketed, with multiple techniques developed to bring 3D 31 culture in compatibility with high-throughput systems (Wrzesinski 2015, Nierode 2016). Over the years, 32 multiple advantages of 3D culture systems were highlighted, including increased physiological relevance, 33 ability to dissect the cellular and molecular biology of structures and niches unavailable in 2D cultures, 34 such as epithelial tubes, breast tissue acini and the tumor microenvironment. Currently 3D cell cultures are 35 used to study a broad range of questions, including differentiation, toxicology, tumor biology, 36 morphogenesis and tissue architecture, as well as general cellular properties such as gene or protein 37 expression and cell physiology (Ravi 2015) . Multiple culture systems are currently available, ranging from 38 gel-like matrices made from biological extracellular matrix (ECM) components (i.e. Matrigel®, Collagen 39 I), synthetic hydrogel scaffolds (i.e. PEG, PLA) and scaffold-free techniques, such as hanging drop, low-40 adhesion aggregation or forced flotation (Edmondson, 2015) 41
The general premise of a 3D culture system is to place an individual cell or a cell aggregate into a 3D 43 matrix, typically a gel or a synthetic scaffold, in which the cells are allowed to grow in all directions. The 44
properties of the matrix are chosen to ensure a physiologically relevant model, with stiffness, ligand 45 presence, and matrix composition typically taken into account. The starting cellular material can also be 46 varied in its level of organization and complexity -from a single cell, which will be allowed to propagate 47 in 3D, to a pre-formed clump of cells, to an organoid with distinct tissue architecture. 48 49
However, the widespread adoption of 3D culture systems has been slow due to the technical difficulties of 50 setting up and maintaining the systems as well as the limited toolbox of manipulations and analyses that 51
have been developed to study cells confined in scaffolds. On one side, complicated protocols, high costs of 52 reagents, and long wait times between system setup and ready to use 3D cultures, deter researchers from 53 using 3D setups. On the other side, the limitations of many models, such as high batch-to-batch variability, 54
difficulties manipulating gene expression in 3D, and extracting DNA and protein from the scaffold-55
confined cells have also contributed to the slow spread of 3D culture use (Katt 2016) 56 57
Here we present a new model system with distinct advantages over previous models. First, it is designed to 58 represent the physiological organization of epithelial tissues, with cell aggregates that are surrounded by a 59 model of the basement membrane, which are then further embedded in a collagen-I hydrogel modeling the 60 ECM of connective tissue. In addition, we have developed tools to change the stiffness of this hydrogel to 61 mimic tissues with different mechanical properties. Furthermore, we have developed this model to 62 maximize efficiency and time-to-experiment readiness, and to minimize cost and complexity. And finally, 63
we have refined a set of tools to allow the researcher to manipulate and analyze cells within this 3D culture 64 system, which should expand the utility of this setup. This system can be used to address a wide variety of 65 experimental questions, but here we will use two examples from our work on epithelial morphogenesis and 66 on the tumor microenvironment to illustrate the flexibility of the protocol. 67 68 3D culture of polarized epithelial cells 69
Apical-basal polarization is one of the key processes of normal epithelial organization, with defects in 70 polarization often being a hallmark of malignancy (Overeem 2015 when used as a hydrogel, it loses the structural organization of the sheet-like basement membrane, and 85 collagen-I, while a good biochemical and structural model of the connective tissue ECM, necessitates that 86 the epithelial cells secrete their own basement membrane, which can take a significant amount of time. 87 88 3D culture of cancer cells 89
A research area that has significantly benefitted from the development of 3D cell cultures is using cancer 90 cells to model the tumor microenvironment and tumor-stoma interactions. Collagen-I hydrogels were one 91 of the earliest 3D methods used to study the response of cancer cells to the extracellular matrix (ECM) 92 (Richards et al., 1983) . Many reports have been published examining the behavior of tumor cells in 93 collagen-I or other, more specialized or defined, 3D matrices, but few if any of these models were 94
representative of the organization of pre-metastatic tumors. Cells from a tumor in situ are exposed to a 95 different ECM than metastatic cells; specifically, a tumor in situ is encapsulated within a basement 96 membrane (BM), while a metastatic cell has left the tumor site and invaded into the connective tissue 97 stroma. The basement membrane and the stroma are composed of different constituent components. BM is 98
primarily made up of type IV collagen, laminin, and heparan-sulphate proteoglycans (Kalluri, 2003) , while 99 the stroma is largely made up of type I collagen and elastin (Culav et al., 1999) . The physical characteristics 100
of the two compartments differ as well; a solid tumor is typically much stiffer than the surrounding stroma Reagents 108
• Acetic acid (glacial; C2H4O2) 109
• Bovine serum albumin (BPA; product BP9703, Fisher Scientific) 110
• Collagenase (product 02195109, MP Biomedicals) 111
• Collagen-I (product 150026, MP Biomedicals) 112
• Dimethyl sulfoxide (DMSO; product D2650, Sigma-Aldrich) 113
• Distilled water (ddH2O) 114
• DMEM (product 10-013-CV, Corning) 115
• Ethylene glycol-bis(succinic acid N-hydroxysuccinimide ester) aka PEG-diNHS (product E3257, 116
Sigma-Aldrich) 117
• Glassware (bottles with caps: 100 mL, 1 L) 118
• Goat serum (product G6767, Sigma-Aldrich) 119
• Growth factor reduced Matrigel® (product 354230, Corning) 120
• Magnetic stirrer and stir bar 121
• OPTI-MEM I (product 31985-070, Life Technologies) 122
• Paraformaldehyde solution (product 18814, Polysciences Inc) 123
• SlowFade® Diamond (ThermoFisher Scientific) 124
• Sodium azide (NaN3; product 190385000, Acros Organics) 125
• Sodium chloride (NaCl; product S5886, Sigma-Aldrich) 126
• Sodium phosphate dibasic (Na2HPO4; product S5136, Sigma-Aldrich) 127
• Sodium phosphate monobasic (NaH2PO4; product 71505, Sigma-Aldrich) 128
• Sodium pyruvate (prodct 11360070 129
• Triton X-100 (product BP151, Fisher Scientific) 130
• µ-Slide 8-well Glass Bottom chamber slide (product 80827, Ibidi) 131
• 1.5 mL disposable microcentrifuge tubes 132
• 4D-Nucleofector® X Kit (product V4XC-1032, Lonza) 133
• 10 cm cell culture dishes (product 172958, Thermo Scientific) 134
• 15 mL disposable conical tube with cap (product 352097, Becton Dickinson) 135
• 35 mm tissue culture dishes (product10861-586, VWR) 136
• 35 mm glass bottom microwell dish (product PG5G-1.5014-C) 137
• 50 mL disposable conical tube with cap (product 82018-050, VWR) 138
• 60 mm tissue culture dishes (product 10062-890, VWR) 139
• 96-well round bottom ultra-low attachment microplates (product 7007, Corning) 140
• 100 mm tissue culture dishes (product 10861-594, VWR) 141 142
Equipment 143
• Class II microbiological safety cabinet 144
• CO2 cell culture incubator 145
• Fluorescent and light microscope (model DMI4000 B, Leica Microsystems) 146
• Forceps 147
• Hemocytometer 148
• Nutating shaker (model 117, TCS Scientific) 149
• Kimwipes (product S-8115, Kimberly-Clark) 150
• Pipettes with non-sterile and sterile plastic tips (P2, P20, P200 and P1000) 151
• Rotational shaker (product 6780-FP, Corning) 152
• Manassas, VA) under 5% CO2. For both cell lines, cells from passage 5 -25 were used. 165
Preparation of polarized epithelial spheroids 166
An overview of the epithelial spheroid model production protocol is depicted in Figure 1 . Briefly, MDCK 167 cells are harvested through trypsinization and counted. Pipette 250,000 cells in 1 mL of fresh culture media 168 into a 15 mL conical tube. Then add 500 µL of 3 mg / mL growth factor-reduced Matrigel® diluted in 169
OPTI-MEM I media to the cell solution. This results in a final concentration of 1 mg/mL Matrigel®, which 170 is below the concentration necessary for gelation. This allows the basement membrane extracellular matrix 171
(ECM) components in Matrigel® to adsorb to the cell surface and jumpstart the formation of the basement 172 membrane. The tube should then be placed on its side in the incubator with the cap partially open to allow 173 air exchange, and incubated overnight. This will allow the cells to coalesce into small cell clumps. Most 174 epithelial cells will preferentially adhere to one another rather than the non-tissue culture plastic of the tube. 175
If the cells adhere to the tube, try tubes from different manufacturers. 176 177
Cell aggregates can then be left to mature into spheroids in the Matrigel® suspension, or immediately 178 incorporated into collagen-I hydrogels (Figure 1 B and 
Incorporation of tumor spheroids into hydrogels
Hydrogels are prepared as above. Briefly, collagen-I stock solution is combined with neutralizing solution 214
and cell suspension media at a ratio of 615 : 312 : 77. Alternately, poly (ethylene glycol)-di (succinic acid N-215 hydroxysuccinimide ester) (PEG-diNHS) dissolved in DMSO (100 mg / mL, product E3257, Sigma-216
Aldrich, molecular weight 456.36) can be added to the gel to increase the gel stiffness by crosslinking the 217 collagen fibers. In our hands, a ratio of 615 : 308 : 77 : 4 for collagen-I : suspension media: neutralizing 218 solution: PEG-diNHS / DMSO resulted in a fourfold increase in gel stiffness (from ~200 Pa to ~800 Pa) 219
(McLane and Ligon, 2015). These gels can also be pre-populated by stromal cells, such as fibroblasts by 220
adding fibroblasts into the collagen solution prior to gelation (McLane and Ligon, 2016).
222
To make spheroid-containing hydrogels, transfer pre-formed spheroids in 2 μL media droplets to 10 cm 223 dishes (eight spheroids per dish). Add 100 μL of collagen-I solution to each spheroid droplet, briefly mixing 224
in the pipette tip and re-depositing in the dish. Incubate dishes for 45 min at 37 °C to allow gels to form, 225 then add 10 mL culture media to the dish and release the hydrogels from the surface with a spatula. Culture 226 all hydrogels on an orbital shaker to ensure they do not reattach to the culture vessel.
228
Transfection of spheroids with plasmid DNA 229
To transfect cells in spheroids, allow them to form to the desired stage in suspension (e.g. grow epithelial 230 spheroids to full polarity for 5 days). Wash 1 mL of spheroids in suspension as described above. Spin 231 spheroids down gently to pellet and aspirate the media, then add 100 µL of SE Cell Line 4D-Nucleofector® 232 X Kit and transfect with 4 µg of plasmid of choice. Here we used GFP plasmid (Clonetech, currently Takara 233
Bio USA, Fremont, CA) diluted in MilliQ sterile-filtered water ( Figure 1C ). Transfect the cells using the 234 4D-Nucleofector protocol CA-152. After transfection, transfer the spheroids to a 35-mm dish with 2 mL of 235 fresh warm media and leave spheroids for four hours to recover post-transfection. To form spheroid-236
containing hydrogels, collect the spheroids, briefly spin down and re-suspend in 400 µL of culture media.
237
The spheroids then can be seeded in collagen gels as described above. A simplified illustration of 3D 238 transfection workflow is shown in Figure 1C . 239
Immunocytochemistry 240
The cells in the hydrogels can be stained for protein markers using conventional primary and secondary 241
antibodies. The spheroids in gels are fixed with 4% paraformaldehyde in PBS for 45 min at 37°C, then 242 permeabilized with 0.25% Triton-X in dH2O for 45 min at room temperature, washed briefly with PBS + 243 0.05% sodium azide (PBS-NaN3), and blocked for 2 hr at room temperature or overnight at 4°C in blocking 244 solution (5% goat serum, 1% BSA, 0.05% NaN3 in PBS). Spheroids can then be incubated with primary 245 antibodies diluted in PBS + 0.05% sodium azide overnight at 4°C. For that purpose, gels and diluted 246
antibodies are placed in 1.5 mL conical tubes on a nutating shaker. Primary antibody incubation is followed 247 by three PBS-NaN3 washes, 60 minutes each. Then, secondary antibodies and stains, such as DAPI or 248 phalloidin diluted in PBS + 0.05% sodium azide are applied overnight at 4°C. The three 60 min washes 249
with PBS-NaN3 are repeated after the overnight incubation. Fixed hydrogels with spheroids can be stored 250 in 1.5 mL conical tubes in PBS-NaN3. 251
In the example shown here ( Figure 3 ) the primary, antibodies used were: alpha tubulin @ 1: 500 (product 252 T9026, Sigma-Aldrich, St. Louis, MO; Collagen-IV, product GTX26311, GeneTex, Irvine, CA). Secondary 253 antibodies were used @ 1:300 (Alexa Fluor, Jackson labs, Bar Harbor, ME) together with rhodamine 254 phalloidin for f-actin (product P1951, Sigma-Aldrich, St. Louis, MO) and DAPI (4',6-diamidino-2-255 phenylindole). 256
Microscopy 257
The spheroids in the gels can be imaged at high magnification using both DIC and fluorescent microscopy. 258
To prepare fixed cells for a imaging, place a gel in a 35 mm glass-bottom dish (MatTek), remove excess 259 PBS with a Kimwipe and apply a drop of SlowFade® Diamond antifade mountant, allowing the gel to 260 incorporate the antifade reagent for approximately 1 minute, and then placing a glass coverslip on top to 261 flatten the gel, optionally adding a 1 g precision weight on top to further flatten the gel. 262
In the example shown here (Figure 3 ), imaging was done on an inverted microscope (DMI 4000B Inverted 263
Microscope, LEICA Microsystems) outfitted with an ORCA-ER digital camera (Hamamatsu Photonics) 264
and a Yokogawa spinning disc confocal using Volocity imaging software (Improvision/PerkinElmer).
266
Cell isolation for nucleic acid or protein extraction 267
Protein and nucleic acid can be extracted from the cells grown in hydrogels for use in western blotting, 268
PCR, and other application. To isolate cells, treat the gels with collagenase (product 02195109, MP 269
Biomedicals) at 10 mg/mL until gels are digested (30 to 60 min). During digestion, place the tubes on a 270 rotational shaker at 37 °C and monitor the tubes in five minute increments until the gels are completely 271
digested. Centrifuge the digested gels at 300 xg for 5 minutes to pellet cells, and aspirate the digested 272 collagen with a pipette. Wash the cell pellets twice with PBS by re-suspending cells in 1 mL PBS and re-273 pelleting cells with 300 xg spin. The cells can be then frozen, or used for nucleic acid or protein extraction 274 using standard protocols. 275 276
RESULTS AND DISCUSSION 277
Here, we present a method to generate a model epithelial tissue, in which the organization, composition and 278 physical properties of the ECM are physiologically appropriate, composition is controlled, and stiffness can 279 be tuned (McLane and Ligon, 2016). This model system can be used to recapitulate normal epithelial 280 organization, or an early in situ tumor. In both cases, the cells are encased in a basement membrane, initially 281 nucleated by Matrigel®, and then are surrounded by a stiffness-controlled stromal matrix, composed of 282 type I collagen, in which stromal cells such as fibroblasts can also be embedded. Other ECM components 283
can be added in to the stromal mixture as well to increase the physiological accuracy. 284 285
Formation of normal polarized epithelial spheroids 286
The spheroids formed with the dual matrix method show early and robust polarization. As shown in Fig. 3,  287 spheroids at day 1 are composed of multiple cells, distinctly visible with F-actin labeling (red). By day 3, 288
the cells in spheroids have begun to assume the columnar morphology characteristic of polarized epithelial 289 cells, and the spheroid has also begun to establish a hollow core. By day 6, the cells in the spheroids show 290 distinct polarized morphology, and the hollow core is fully formed. In comparison, single cells seeded in a 291 collagen-I gel form a mostly disorganized clump of cells by day 3, and do not show signs of polarization 292
(columnar cell morphology, hollow core formation) by day 6. This side-by-side comparison clearly 293
illustrates the increased speed of polarization and spheroid formation in the dual-matrix system as compared 294
with a single matrix collagen-I system. 295 296 297
Formation of tumor spheroids 298
Tumor cell spheroids formed with the dual matrix method demonstrate behaviors characteristic of a tumor 299
in-situ, such as matrix invasion, while spheroids formed of cells of non-metastatic lineage do not (McLane 300
and Ligon, 2016). This normalized behavior from non-metastatic cells, the expected original hypothesis, is 301 not what has been historically observed in single matrix culture models and is apparently mediated by the 302 establishment of a basement membrane prior to hydrogel incorporation. This clearly illustrates the 303 importance of the dual matrix system and the ability to mimic the in-vivo microenvironment in comparison 304
to single matrix systems. 2008). However, altering these parameters or incorporating a secondary material alters the structure of the 328 hydrogel and/or availability of the collagen-I ligand. To avoid these potential changes, we control collagen-329 I hydrogel stiffness independently of pH, temperature and protein concentration and without the 330 incorporation of a second material by crosslinking the collagen-I with poly-(ethylene glycol)-di (succinic 331 acid N-hydroxysuccinimide ester) (PEG-diNHS) (Abdella et al., 1979) . PEG-diNHS makes short crosslinks 332 between proteins by forming amide bonds between the collagen-I and itself to tether collagen molecules 333 together, which mimics cross-links formed in vivo (Wallace, 2003) . These collagen-I PEG-diNHS 334
hydrogels have been previously used in studies of tumor spheroid formation and in tissue engineering, and The basement membrane (BM) extracellular matrix is made up of different proteins from that of connective 342 tissue, and those that are shared between the two are present in different concentrations (Shoulders and 343 Raines, 2009). In the case of normal epithelial tissue or a carcinoma in situ, an early stage in tumor 344 development in which the BM is still intact, the cells are surrounded by the BM. Tumor cells must degrade 345 this BM or otherwise circumvent it before invading into the stromal tissue. Our model of both normal 346 epithelial spheroids and of a tumor in situ utilizes Matrigel®, a commercially available sarcoma produced 347 protein mixture rich in basement membrane proteins (Hughes et al., 2010) , to jumpstart BM formation. To 348 accomplish this, we form cell aggregates or spheroids in the presence of dilute Matrigel®. We use 349
Matrigel® at a concentration below the critical gelation concentration, so it does not form a gel, but allows 350 basement membrane components to be adsorbed to the surface of the cells during aggregate or spheroid 351
formation. Most epithelial cells will also secrete basement membrane proteins and form a basement 352 membrane by themselves, but this process can take over a week. By providing building blocks, we can 353 significantly accelerate basement membrane formation. We then incorporate the BM-coated spheroid into components to accelerate the formation of a basement membrane. These formed spheroids are then 369 incorporated into the stromal matrix after a coherent structure in which the cells have developed significant 370 apical-basal polarity has formed. We believe this is more representative of a tumor in situ and will yield 371 more translational results as tumors develop from existing tissue, not from single cells within a matrix. We 372
have recently used this method to show that spheroids of both normal MCF10A cells and more metastatic 373
MDA-MB-231 cells behave somewhat differently than when grown in a less physiologically relevant 374 system (McLane and Ligon, 2016). For example, it has previously been suggested that the phenotypically 375 normal MCF10As become invasive when grown in a stiff matrix, but we showed that when the MCF10As 376 are grown in this physiologically appropriate two matrix system, they do not show an invasive phenotype 377 with increased stromal stiffness. 378 379 Similar to the methods described above to investigate the tumor microenvironment, studies of normal 380 epithelial biology in 3D have also typically started from single cells seeded in a collagen-I matrix, and then 381 allowed to develop for 10-12 days into mature cysts (Montesano 1991, reviewed in Zegers 2003, Belmonte 382 2008). In other studies, cells were seeded in Matrigel® instead (Belmonte 2008). In both cases, the 383 organization of the model did not fully recapitulate normal tissue arrangement. In addition, another 384 drawback to this approach is that during the long incubation necessary to achieve fully polarized spheroids, 385 some cells can migrate away from the spheroid to the edge of the gel, where they form a 2D monolayer that 386
can interfere with imaging, and perhaps alter the mechanical properties of the matrix. 387 388
We have found that growing cells in a sub-gelation concentration of Matrigel® prior to seeding them in 389 collagen-I promotes the formation of small multi-cell clusters (nucleated aggregates). Seeded into the 390 collagen gel, these starter spheroids develop into mature spheroids in ~5-6 days, thus shortening the 391 experiment preparation time by ~60% or up to 6 days. Alternatively, spheroids can be grown to full 392 polarization in the dilute Matrigel® solution before incorporation into the collagen-I gel, which further 393 increases the maturation speed, with most spheroids ready to use by day 4. 394 395
Another major issue in 3D cell culture is that it is difficult to perform genetic manipulations on cells that 396 are encapsulated in a hydrogel. One way around this limitation is to create stably transfected cell lines with 397 a drug-inducible construct. Here we have developed methods to manipulate cells while they are growing in 398 the dilute Matrigel® solution via methods such as electroporation (Nucleofection™), lipid-based reagents 399 or iron-oxide nanoparticles (Magnetofection™). We have recently used this model system to investigate 400 the mechanisms of epithelial morphogenesis and have shown that spheroids grown with this method display 401 the same markers of polarity and respond to growth factor stimulation in the same way as the traditional 402 spheroids grown in collagen-I (Bogorodskaya and Ligon, submitted). 403 404
Controls and caveats 405
While we discuss the basics of spheroid formation and collagen-I hydrogels, it is important to note that 406
there are a large number of parameters that can affect the properties of the model system. Altering a 407 parameter can drastically change the collagen-I fiber size, hydrogel porosity, mechanical properties, 408 spheroid size, spheroid number and cell survival.
410
As with any culture system, selection of cell culture media is critical and the effects of different media on 411
all cell types used in the system must be evaluated. Cross-linkers can cause viability issues with some cell 412 types, so we also recommend evaluating the viability of your cells after incorporation into the PEG-diNHS 413 cross-linked collagen-I stromal hydrogel. Finally, there are many opportunities for variation in preparing 414
the various reagents used in making the hydrogels, so we also recommend evaluating the stiffness of the 415 collagen-I hydrogels to ensure that they are of desired stiffness. We have done so via bulk rheometry, but 416 other methods such as extensiometry ( Limitations 420
The initial size of spheroids may be potentially limiting for some experimental scenarios. Although it is 421 possible to generate very large spheroids, for this method, the spheroid must fit through the opening of 422 micropipette tips (we use 200 μL tips for all of our spheroid handling) and scale to the volume of the tip. 423
This limitation is however easily overcome by using larger pipettes and larger volumes of hydrogel. 424
Although we have observed no nutrient limitation or waste product induced cell death at the scale we have 425 used (spheroids up to ~2 mm 3 ), these are potential concerns for larger spheroids. For polarized cysts, the 426 size of the resulting cyst will be dependent on the initial starter spheroid, and high variability of cyst sizes 427 in possible, with spheroids ranging from 100 µm to 500 µm and larger in diameter. For cysts left to mature 428 in Matrigel® suspension, most of the cysts will be ready on day 4, but those left in Matrigel® will continue 429 increasing in size, reaching up to 500 µm in diameter. 430 431 432 ACKNOWLEDGEMENTS 433 434
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